Wells Fargo & Company Agile Therapeutics Inc Transaction History

Wells Fargo & Company

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.21 - $0.31 $9 - $13	45 Added 16.25%	322 $0
Q4 2022 Feb 13, 2023	BUY	$0.18 - $15.25 $3 - $274	18 Added 6.95%	277 $0
Q3 2022 Nov 14, 2022	BUY	$0.28 - $14.85 $30 - $1,603	108 Added 71.52%	259 $0
Q2 2022 Aug 12, 2022	BUY	$1.09 - $8.24 $164 - $1,244	151 New	151 $0

Ticker AGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 39,023,000
Description
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.